Related Experiment Video
Updated: Oct 4, 2025

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae
Published on: January 17, 2014
Streptococcus pneumoniae colonization associates with impaired adaptive immune responses against SARS-CoV-2
Elena Mitsi1, Jesús Reiné1, Britta C Urban1
1Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Abstract:
BackgroundAlthough recent epidemiological data suggest that pneumococci may contribute to the risk of SARS-CoV-2 disease, cases of coinfection with Streptococcus pneumoniae in patients with coronavirus disease 2019 (COVID-19) during hospitalization have been reported infrequently. This apparent contradiction may be explained by interactions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and pneumococci in the upper airway, resulting in the escape of SARS-CoV-2 from protective host immune responses.MethodsHere, we investigated the relationship of these 2 respiratory pathogens in 2 distinct cohorts of health care workers with asymptomatic or mildly symptomatic SARS-CoV-2 infection identified by systematic screening and patients with moderate to severe disease who presented to the hospital. We assessed the effect of coinfection on host antibody, cellular, and inflammatory responses to the virus.ResultsIn both cohorts, pneumococcal colonization was associated with diminished antiviral immune responses, which primarily affected mucosal IgA levels among individuals with mild or asymptomatic infection and cellular memory responses in infected patients.ConclusionOur findings suggest that S. pneumoniae impair host immunity to SARS-CoV-2 and raise the question of whether pneumococcal carriage also enables immune escape of other respiratory viruses and facilitates reinfection.Trial registrationISRCTN89159899 (FASTER study) and ClinicalTrials.gov NCT03502291 (LAIV study).
Insights
Pneumococcal colonization weakens the immune response to SARS-CoV-2 (coronavirus disease 2019). This coinfection may allow the virus to evade immune defenses, potentially leading to reinfection.
Area of Science:
- * Immunology
- * Virology
- * Microbiology
Background:
- * Epidemiological data suggest pneumococci increase SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) risk.
- * Infrequent reports of Streptococcus pneumoniae coinfection in hospitalized COVID-19 patients suggest complex interactions.
- * Potential SARS-CoV-2 immune evasion mechanisms in the upper airway due to pneumococci.
Purpose of the Study:
- * Investigate the relationship between SARS-CoV-2 and pneumococcal coinfection.
- * Assess the impact of coinfection on host immune responses (antibody, cellular, inflammatory).
- * Examine these interactions in both mild/asymptomatic and moderate/severe COVID-19 cases.
Main Methods:
- * Studied two cohorts: healthcare workers with asymptomatic/mild SARS-CoV-2 and hospitalized patients with moderate/severe COVID-19.
- * Systematic screening for SARS-CoV-2 infection.
- * Assessed host immune responses to SARS-CoV-2 in the presence of pneumococcal colonization.
Main Results:
- * Pneumococcal colonization was linked to reduced antiviral immune responses in both cohorts.
- * Mucosal IgA levels were primarily affected in mild/asymptomatic infections.
- * Cellular memory responses were diminished in hospitalized patients with coinfection.
Conclusions:
- * Streptococcus pneumoniae impairs host immunity against SARS-CoV-2.
- * Pneumococcal carriage may facilitate SARS-CoV-2 immune escape.
- * Raises questions about pneumococcal role in immune evasion and reinfection for other respiratory viruses.
More Related Videos
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
09:20Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay
Published on: April 28, 2014
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...